Viewing nowCombinationEsca Tablet 5/20mg
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.

MFDS item code 201902221 · Approved 2019.04.11 · Insurance code 644004130
Treatment of essential hypertension not adequately controlled with monotherapy
This medication is used to improve blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or olmesartan medoxomil.
Administer 1 tablet of this drug once daily with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended that the dose of the individual component (amlodipine or olmesartan medoxomil) be adjusted; however, if blood pressure is not controlled with monotherapy with an individual component, switching directly to this drug may be considered. The maximum dose of this drug is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This drug has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild and moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily, and administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: For patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose with close monitoring of their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild and moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics, blood pressure and renal function should be closely monitored. Do not administer this drug to patients with severe hepatic impairment. (See section 2, Patients who should not receive this drug, under Precautions for Use.) ∘Older adults: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in older adults.
∘Children: The safety and efficacy have not been established in pediatric patients under 18 years of age.
This medication can cause severe harm to the fetus if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with allergies to it, those who are pregnant or breastfeeding, patients with severe liver disease or aortic stenosis, patients undergoing renal dialysis, patients in shock, or patients with certain kidney diseases or diabetes. In patients who are depleted of fluids or salt, hypotension may occur, so they should be monitored closely while taking this medication. Vasodilation can lead to hypotension, so patients with heart or vascular diseases should take care. In heart failure patients or those with decreased kidney function, there is a risk of worsening kidney function or hypotension, so it should be used with caution. Patients with poor liver function should be careful as the drug may remain in the body for a longer time. While taking this medication, side effects such as dizziness, headache, hypotension, edema, digestive discomfort, etc., may occur, so consult a doctor if there are any abnormal symptoms. Taking this medication during pregnancy may cause serious problems for the fetus, so those planning to become pregnant or who are pregnant should definitely consult a doctor. In breastfeeding women, this medication can be transmitted through breast milk and may affect the infant, so it is recommended to either temporarily stop breastfeeding or discontinue the medication. For children under 18 years of age, the safety and effectiveness of this medication have not been established, and its use is not recommended. Elderly patients should start at a low dose due to decreased kidney and liver function, and should take it with caution. In case of overdose, symptoms of hypotension and effects from vascular dilation may occur, and if symptoms are severe, immediate medical treatment should be sought. This medication should be stored in a tightly sealed container, away from direct sunlight and moisture, and out of reach of children.
Drug hypersensitivity, hyperkalemia, decreased libido, dizziness, headache, orthostatic hypotension, drowsiness, paresthesia, sensory impairment, syncope, vertigo, palpitations, tachycardia, hypotension, orthostatic hypotension, dyspnea, cough, nausea, vomiting, dyspepsia, diarrhea, constipation, dry mouth, upper abdominal pain, rash, urticaria, muscle tension, limb pain, low back pain, polyuria, erectile dysfunction, peripheral edema, edema, pitting edema, fatigue, asthenia, facial edema, decreased serum potassium, increased serum creatinine, increased serum uric acid, increased gamma-glutamyl transferase, decreased hemoglobin and hematocrit, cholelithiasis, female breast neoplasm, exacerbation of cerebral infarction, gum bleeding, chest pain, cold, increased CRP, fever, hemoptysis, excessive sneezing, runny nose, laryngitis, arthritis, flank pain, generalized pain, hypoglycemia, weight loss, heartburn, gastroenteritis, shingles, diplopia, insomnia, asthenia, angioedema, chronic malabsorption syndrome - similar intestinal disorder, intestinal vascular edema, rhabdomyolysis, acute renal failure, hair loss, itching, autoimmune hepatitis, flushing, fatigue, edema, palpitations, vertigo, headache, drowsiness, abdominal pain, nausea, gynecomastia, jaundice, elevated liver enzymes, leukopenia, thrombocytopenia, toxic epidermal necrolysis, hypotension, tachycardia, bradycardia, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.
White, round, film-coated tablet
PTP - 14 tablets/PTP [28 tablets (14 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.